Under Vitro’s bankruptcy restructuring plans, the Mexican-glass maker’s bondholders will have to take a $650 million loss on their investment, The Wall Street Journal reports. The company secured an approval in Mexico last year for a restructuring plan. The reorganization plan will leave the company’s stockholders, including the Sadas, almost unharmed. Currently, Vitro’s three-front strategy includes gaining approval for its restructuring plan in Mexico, gaining U.S. recognition of its Mexican case in New York and selling four U.S. units through a bankruptcy sale in Texas.

Click here for the story from The Wall Street Journal.